Tipranavir and Levoketoconazole: Interaction Details

Brand names
Tipranavir
Aptivus
Levoketoconazole
Recorlev
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Tipranavir and Levoketoconazole interaction:

Share

Share this interaction

What Happens When You Take Tipranavir With Levoketoconazole

What can happen when they are taken together (rated Contraindicated)

Increased tipranavir exposure, an increased risk of serious and drug-induced liver injury

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Using levoketoconazole together with tipranavir, or with any other sensitive that is hepatotoxic, is . Levoketoconazole inhibits CYP3A4, so when it is given alongside a sensitive CYP3A4 substrate, exposure to that substrate may rise, which may raise the likelihood of adverse reactions, severe hepatotoxicity among them.1

The Tipranavir and Levoketoconazole Interaction, Explained

These two medicines should not be taken together. Levoketoconazole (Recorlev) can slow the liver enzyme () that helps clear tipranavir (Aptivus), an HIV medicine. That could cause tipranavir to build up in the body. Tipranavir can already stress the liver, so higher levels may raise the chance of serious liver injury. This concern is based on how the drugs work rather than on reported cases, but it is taken seriously. Levoketoconazole itself can also affect the liver.

If you take either medicine, keep taking them as prescribed and talk with your pharmacist or doctor soon. Your care team can review your options and decide on the safest plan for you.

(theoretical evidence). Levoketoconazole is a . Tipranavir is a CYP3A4 with a for (including decompensation) and intracranial . of CYP3A4 may increase tipranavir exposure (/), raising the risk of severe hepatotoxicity and drug-induced liver injury. Levoketoconazole carries its own hepatotoxicity warning, so the hepatic risk may be .

  • Onset: unspecified.
  • Management: is contraindicated per labeling.
  • Consider alternative therapy for one agent, with prescriber guidance.
  • If exposure has occurred, monitor liver function and for symptoms of hepatotoxicity.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Tipranavir and Levoketoconazole Interact

The likely mechanism

of -substrate by levoketoconazole

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Tipranavir and Levoketoconazole Interaction

The documented management is that these two medicines should not be used together. This is based on how the drugs are expected to interact, not on confirmed cases.

  • Keep taking your medicines as prescribed until you speak with your care team. Do not stop either one on your own.
  • Tell your pharmacist and prescribers about every medicine you take, including both of these.
  • Your care team may choose a different medicine for one of the conditions being treated.
  • Report signs of liver trouble right away, such as yellow skin or eyes, dark urine, severe tiredness, nausea, or belly pain.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Tipranavir or Levoketoconazole need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: RECORLEV oral tablets, levoketoconazole oral tablets

    When levoketoconazole 400 mg once daily was given together with felodipine (a sensitive ), felodipine and rose by 1007% and 937%, respectively, relative to felodipine given alone (N=14).1

Tipranavir and Levoketoconazole: Common Questions

How serious is the Tipranavir and Levoketoconazole interaction?

It is rated . These should generally not be used together.

How is the Tipranavir and Levoketoconazole interaction managed?

The documented management is that these two medicines should not be used together. This is based on how the drugs are expected to interact, not on confirmed cases. Keep taking your medicines as prescribed until you speak with your care team. Do not stop either one on your own. Tell your pharmacist and prescribers about every medicine you take, including both of these. Your care team may choose a d… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Tipranavir and Levoketoconazole Interaction

Ask in your own words about taking Tipranavir and Levoketoconazole together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: RECORLEV(R) oral tablets, levoketoconazole oral tablets. Xeris Pharmaceuticals Inc (per FDA), Chicago, IL, 2023. DailyMed
Was this write-up helpful?

Other Serious Interactions of Tipranavir and Levoketoconazole

Also serious with Tipranavir

Also serious with Levoketoconazole

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Tipranavir

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together. This interaction.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.